Adenovirus-specific T-lymphocytes (haploidentical donor)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenovirus-specific T-lymphocytes (haploidentical donor), covering 2025-05-13 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections [Phase 1, Phase 2]